摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-溴-4-(三氟甲基)硝基苯 | 132839-58-8

中文名称
2-溴-4-(三氟甲基)硝基苯
中文别名
2-溴-1-硝基-4-(三氟甲基)苯
英文名称
2-bromo-1-nitro-4-(trifluoromethyl)benzene
英文别名
3-bromo-4-nitrobenzotrifluoride
2-溴-4-(三氟甲基)硝基苯化学式
CAS
132839-58-8
化学式
C7H3BrF3NO2
mdl
——
分子量
270.006
InChiKey
DJOLBPUSSIOMKU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    224.8±40.0℃ (760 Torr)
  • 密度:
    1.788±0.06 g/cm3 (20 ºC 760 Torr)
  • 闪点:
    89.7±27.3℃

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    14
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    45.8
  • 氢给体数:
    0
  • 氢受体数:
    5

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    T
  • 海关编码:
    2904909090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:f1f7eec5d24d23b4efb822a8753416c3
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Bromo-1-nitro-4-(trifluoromethyl)benzene
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
Avoid breathing dust/fume/gas/mist/vapours/spray
P261:
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

Section 3. Composition/information on ingredients.
Ingredient name: 2-Bromo-1-nitro-4-(trifluoromethyl)benzene
CAS number: 132839-58-8

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H3BrF3NO2
Molecular weight: 270.0

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen fluoride, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    2-溴-4-(三氟甲基)硝基苯盐酸 作用下, 以 乙醇 为溶剂, 反应 6.5h, 生成 2,2'-diamino-5,5'-bis(trifluormethyl)biphenyl
    参考文献:
    名称:
    合成取代基9,9-双(正丁基)二苯并锡
    摘要:
    报道了五个9,9-双(正丁基)二苯并锡的合成,它们分别被3-和6-中的两个F 3 C-,CH 3 O-,(CH 3)3 C取代基对称地二取代。苯环的2-和7-位上的两个F 3 C - CH 3 O-取代基。
    DOI:
    10.1016/0022-328x(91)83061-8
  • 作为产物:
    描述:
    3-氨基-4-硝基三氟甲苯氢溴酸 、 copper(I) bromide 、 sodium nitrite 作用下, 生成 2-溴-4-(三氟甲基)硝基苯
    参考文献:
    名称:
    合成取代基9,9-双(正丁基)二苯并锡
    摘要:
    报道了五个9,9-双(正丁基)二苯并锡的合成,它们分别被3-和6-中的两个F 3 C-,CH 3 O-,(CH 3)3 C取代基对称地二取代。苯环的2-和7-位上的两个F 3 C - CH 3 O-取代基。
    DOI:
    10.1016/0022-328x(91)83061-8
点击查看最新优质反应信息

文献信息

  • Intermolecular Reductive C–N Cross Coupling of Nitroarenes and Boronic Acids by P<sup>III</sup>/P<sup>V</sup>═O Catalysis
    作者:Trevor V. Nykaza、Julian C. Cooper、Gen Li、Nolwenn Mahieu、Antonio Ramirez、Michael R. Luzung、Alexander T. Radosevich
    DOI:10.1021/jacs.8b10769
    日期:2018.11.14
    intermolecular C-N coupling is reported. The method employs a small-ring organophosphorus-based catalyst (1,2,2,3,4,4-hexamethylphosphetane) and a terminal hydrosilane reductant (phenylsilane) to drive reductive intermolecular coupling of nitro(hetero)arenes with boronic acids. Applications to the construction of both Csp2-N (from arylboronic acids) and Csp3-N bonds (from alkylboronic acids) are demonstrated;
    报道了一种通过分子间 CN 偶联合成芳基和杂芳基胺的主要基团催化方法。该方法采用基于小环有机磷的催化剂(1,2,2,3,4,4-六甲基膦烷)和末端氢硅烷还原剂(苯基硅烷)来驱动硝基(杂)芳烃与硼酸的还原性分子间偶联。展示了在构建 Csp2-N(来自芳基硼酸)和 Csp3-N 键(来自烷基硼酸)中的应用;该反应在 Csp3-N 键形成方面是立体有择的。该方法构成了一条从现成的构件到有价值的含氮产品的新途径,与现有催化 CN 偶联方法在范围和化学选择性方面具有互补性。
  • Pd‐Catalyzed Reductive Cyclization of Nitroarenes with CO <sub>2</sub> as the CO Source
    作者:Xinyu Guan、Haoran Zhu、Yingwei Zhao、Tom G. Driver
    DOI:10.1002/ejoc.201901629
    日期:2020.1.9
    A practical, broad‐scope reductive amination process that constructs N‐heterocycles from nitroarenes was developed that uses CO2 as the source of CO.
    开发了一种实用的,广谱的还原胺化工艺,该工艺利用硝基芳烃构建N杂环,并使用CO 2作为CO的来源。
  • [EN] INHIBITORS OF HCV UPJOHN COMPANY<br/>[FR] INHIBITEURS DE LA POLYMERASE DU VHC (NS5B)
    申请人:UPJOHN CO
    公开号:WO2004002940A1
    公开(公告)日:2004-01-08
    The present invention provides compounds of Formula I, compositions and methods that are useful for treating viral infections and associated diseases, particularly HCV infections and associated diseases.
    本发明提供了一种化合物I的公式,以及用于治疗病毒感染和相关疾病,特别是HCV感染和相关疾病的组合物和方法。
  • Discovery of benzophosphadiazine drug candidate IDX375: A novel hepatitis C allosteric NS5B RdRp inhibitor
    作者:Jean-Laurent Paparin、Agnès Amador、Eric Badaroux、Stéphanie Bot、Catherine Caillet、Thierry Convard、Daniel Da Costa、David Dukhan、Ludovic Griffe、Jean-François Griffon、Massimiliano LaColla、Frédéric Leroy、Michel Liuzzi、Anna Giulia Loi、Joe McCarville、Valeria Mascia、Julien Milhau、Loredana Onidi、Claire Pierra、Rachid Rahali、Elodie Rosinosky、Efisio Sais、Maria Seifer、Dominique Surleraux、David Standring、Cyril B. Dousson
    DOI:10.1016/j.bmcl.2017.01.017
    日期:2017.6
    mammalian cells, and as a consequence is an attractive target for selective inhibition. This paper describes the discovery of a novel family of HCV NS5B non-nucleoside inhibitors inspired by the bioisosterism between sulfonamide and phosphonamide. Systematic structural optimization in this new series led to the identification of IDX375, a potent non-nucleoside inhibitor that is selective for genotypes
    丙型肝炎病毒 (HCV) NS5B RNA 依赖性 RNA 聚合酶 (RdRp) 在病毒复制中起核心作用。NS5B 在哺乳动物细胞中没有功能等效物,因此是一个有吸引力的选择性抑制靶标。本文描述了一种新的 HCV NS5B 非核苷抑制剂家族的发现,其灵感来自磺胺和膦酰胺之间的生物等排性。这个新系列的系统结构优化导致了 IDX375 的鉴定,这是一种对基因型 1a 和 1b 具有选择性的强效非核苷抑制剂。IDX375的结构和结合域通过X射线共结晶研究得到证实。
  • Significant Broadening of the Substrate Scope for the Hydrated Imidazoline Ring Expansion (HIRE) via the Use of Lithium Hexamethyldisilazide
    作者:Mikhail Krasavin、Sergey Grintsevich、Alexander Sapegin
    DOI:10.1055/s-0040-1719882
    日期:2022.5
    Abstract

    Substrates that are insufficiently activated towards the hydrated imidazoline ring expansion (HIRE) process have been previously found to deliver exclusively the products of aminoalkyl side-chain ring expansion. Attempted reversal of the process by thermal activation towards HIRE failed. We have found that for such problematic substrates the HIRE-type ring expansion can be effectively achieved by applying lithium hexamethyldisilazide (LHMDS) in toluene. LHMDS is thought to promote intramolecular transamidation, which leads to ring-expanded 10- and 11-membered heterocyclic products in modest to good yields. The process significantly broadens the substrate scope amenable to the HIRE strategy.

    摘要:以前发现,对水合咪唑啉环扩展(HIRE)过程不足激活的底物仅产生氨基烷基侧链环扩展产物。尝试通过热激活向HIRE反转该过程失败。我们发现,对于这类问题底物,可以通过在甲苯中应用六甲基二硅氮化锂(LHMDS)有效实现HIRE型环扩展。认为LHMDS促进分子内转酰胺化,导致产率适中至良好的环扩展的10和11元杂环产物。该过程显著扩大了适用于HIRE策略的底物范围。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐